Form 4: ANI Pharmaceuticals SVP & CFO Stephen P. Carey Reports Stock Transaction
SEC Form 4 Filing
Stephen P. Carey, SVP & CFO of ANI Pharmaceuticals, reported a transaction involving the withholding of shares for tax purposes related to the vesting of restricted stock.
Summary
- On February 29, 2024, Stephen P. Carey, the SVP & CFO of ANI Pharmaceuticals, reported a transaction.
- 1,914 shares of common stock were disposed of at a price of $67.67.
- These shares were withheld for tax purposes in connection with the vesting of 6,079 shares of restricted stock.
- Following the transaction, Carey directly owns 189,715 shares of ANI Pharmaceuticals.
- The transaction was exempt under Rule 16(b)-3.
Sentiment
Score: 7
Explanation: The document is a routine regulatory filing detailing a standard tax-related transaction. It doesn't indicate any significant positive or negative developments for the company.
Industry Context
Form 4 filings are standard disclosures required by the SEC for corporate insiders, providing transparency into their trading activities and ownership positions in their companies.
Key Dates
| Date | Description |
|---|---|
| 02/29/2024 | Date of stock transaction (disposal of shares for tax purposes). |
| 03/01/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.